Brazil mRNA Therapeutics Market Industry Trends and Forecast to 2034: Segmented by (Application, Type, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Overview
Market Dashboard
Brazil · 2024–2034 · placeholder estimates
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the
full report.
Estimate 2024$368.6 MnPlaceholder estimate
Estimate 2025$393.0 Mn2.3% of the global market
Projected 2034$698.5 Mn 77.8%Adds $305.5 Mn over 9 forecast years
CAGR 2025–20346.6%Faster than 19% of 180 Pharmaceuticals markets here
2 in BrazilSource: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Brazil. Retrieved 12 Nov 2026.
Formats
PDF, PPTX, XLSX
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
The Brazil mRNA Therapeutics Market Analysis Executive Summary
mRNA therapeutics use messenger RNA to make the body produce a protein, for vaccines, cancer treatments and rare diseases.
Key segments of the mRNA Therapeutics market include application (Infectious Disease Vaccines, Cancer Vaccines and Protein Replacement) and type (Prophylactic and Therapeutic).
Brazil mRNA Therapeutics market size, 2024–2034. Placeholder estimates; researched figures come with the full report. Source: Acuitas Health Analytics.
Brazil mRNA Therapeutics Market Dynamics
Market Growth Drivers
Approvals of the first curative gene and cell therapies, strong investment in biotech, better manufacturing and growing evidence in rare and blood diseases are driving the mRNA Therapeutics market.
Opportunity
Allogeneic (off-the-shelf) products, in-vivo delivery and use in common diseases open large growth for the mRNA Therapeutics market.
Market Restraints
Very high prices, complex manufacturing, limited treatment centres and uncertain long-term safety hold back the mRNA Therapeutics market. Payers are still working out how to pay for one-time cures.
Competitive Landscape for mRNA Therapeutics Market in Brazil
The mRNA Therapeutics market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Healthcare Policies and Regulatory Landscape for mRNA Therapeutics Market in Brazil
mRNA Therapeutics in Brazil: rules, payment and research
Medicines need registration with ANVISA, the National Health Surveillance Agency, before sale.[1] The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds.[2] ClinicalTrials.gov lists 2 studies on mRNA Therapeutics that are recruiting, active or about to start in Brazil.[3]
[3]ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Brazil. Retrieved 12 Nov 2026.
Policy changes and Reimbursement scenario
Regulators such as the US FDA, the European Medicines Agency and national drug authorities set approval, pricing and safety rules for mRNA Therapeutics. Reimbursement decisions by public payers and insurers shape how fast new therapies reach patients in Brazil.
2.2 Market Size, Growth Prospects and Key findings
3 Market Dynamics
3.1 Market Growth Drivers Analysis
3.2 Market Restraints Analysis
4 Market Segmentation
4.1 By Application
4.2 By Type
4.3 By End User
5 By Market Share
5.1 Market Analysis, Insights and Forecast – By Revenue
6 Competitive Landscape
6.1 Major Top Market Players Products in Pipeline
6.2 R&D Initiatives
6.3 Notable recent Deals
6.3.1 Strategic Divestments
6.3.2 Mergers & Acquisitions
6.3.3 Partnerships
6.3.4 Joint Ventures
7 Key Company Profiles
7.1 Moderna
7.2 BioNTech
7.3 Pfizer
7.4 CureVac
7.5 Arcturus Therapeutics
7.6 Sanofi
8 Healthcare Policies and Regulatory Landscape
8.1 Policy changes and Reimbursement scenario
8.2 Government Initiatives / Intervention programs
The mRNA Therapeutics market can be segmented based on various criteria, including application, type and end user. Here's a breakdown of the market segmentation
Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.
Also active in this area, from free public records
Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.
Beyond the market numbers
Research, trials and patients
What doctors and scientists are doing in mRNA Therapeutics right now, from free public sources.
Sources:PubMed (US National Library of Medicine),
ClinicalTrials.gov,
World Bank.
Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
Public data, with sources
mRNA Therapeutics in context
Brazil compared
Health spending per person: 1,010 US$ per person (2023). World: 1,317 US$ per person (2023). Highest of the 4 countries we cover in Latin America.[1]
Doctors: 2.36 per 1,000 people (2023). World: 1.86 per 1,000 people (2022). 2nd highest of the 4 countries we cover in Latin America.[2]
People aged 65 and over: 11.5% of people (2025). World: 10.4% of people (2025). Highest of the 4 countries we cover in Latin America.[3]
[1]World Bank Open Data, Health spending per person (US$ per person). Retrieved 14 Nov 2026.
How big is the mRNA Therapeutics market in Brazil?
Placeholder estimate: about $393.0 Mn in 2025, rising to about $698.5 Mn by 2034. These are early estimates, not researched figures; the researched values come with the full report.
How fast is the mRNA Therapeutics market in Brazil growing?
Placeholder estimate: about 6.6% a year (CAGR, 2025–2034). The researched growth rate comes with the full report.
What segments does the mRNA Therapeutics market report cover?
The report splits the market by application (Infectious Disease Vaccines, Cancer Vaccines, Protein Replacement, Gene Editing Delivery), type (Prophylactic, Therapeutic) and end user (Hospitals, Specialty Clinics, Retail Pharmacies, Online Pharmacies).
Who are the key players in the mRNA Therapeutics market?
Key players include Moderna, BioNTech, Pfizer Inc., CureVac, Arcturus Therapeutics and Sanofi.
What is driving the mRNA Therapeutics market?
Approvals of the first curative gene and cell therapies, strong investment in biotech, better manufacturing and growing evidence in rare and blood diseases are driving the mRNA Therapeutics market.
Who regulates mRNA Therapeutics in Brazil?
Medicines need registration with ANVISA, the National Health Surveillance Agency, before sale. Source: ANVISA. Checked 14 Nov 2026.
How is healthcare paid for in Brazil?
The Unified Health System (SUS) gives free public care to everyone, and CONITEC advises which medicines and technologies it adds. Source: CONITEC. Checked 14 Nov 2026.
How many clinical trials on mRNA Therapeutics are running in Brazil?
2 studies are recruiting, active or about to start in Brazil, according to ClinicalTrials.gov. Source: ClinicalTrials.gov, Studies recruiting, active or not yet recruiting, in Brazil. Retrieved 12 Nov 2026.
How much research is published on mRNA Therapeutics?
PubMed lists 652 papers on mRNA Therapeutics added since January 2021, worldwide. Source: PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.
Brazil 
Ecuador
US
China
Canada
Japan
Germany
UK
Italy
France
India
Spain
Mexico
Saudi Arabia
Australia
New Zealand
Russia
South Africa
UAE
Egypt
Philippines
Malaysia
Hong Kong
Thailand
Singapore
Kenya
GSK PLC